Controlling the pain and swelling of rheumatoid arthritis is no easy task. As such, treating the disease requires a specialist. A recent study suggests that patients should see a specialist as soon as possible.

When it comes to treating rheumatoid arthritis, there are a number of drugs that can be used. Each drug works differently and has different risks. Do these differences also mean different death rates?

A long term disease named  Ankylosing   Spondylitis has been linked to a higher risk of cardiovascular problems. A number of factors could be responsible for this increased risk, including the drugs used to treat this painful condition.

No two patients with ankylosing spondylitis are exactly the same. As such, a drug treatment that works for one patient may not work for the other. When one drug isn't working out, patients may turn to another drug.

Many experts recommend that rheumatoid arthritis patients get early drug treatment to slow down their disease and prevent disability. With so many drug options, it's important to know the safety of each drug.

A few years ago, the FDA warned that certain drugs may raise the risk of cancer in children with juvenile arthritis. While it still seems these children are more prone to cancer, the drugs might not be to blame.

The inflammation of rheumatoid arthritis can affect more than the joints; it also poses a threat to the heart. When it comes to protecting the heart health of rheumatoid arthritis patients, certain drugs are falling short.